low dose glp-1 microdosing is popular, but there's little evidence it works How GLP-1 medications are transforming

The study employed chitosan nanoparticles as carriers for both a chemotherapy compound and AOD 9604 peptide, hypothesizing that AOD 9604 may potentially facilitate the binding of the compound to multiple protein targets within breast cancer cells in laboratory settings

Low levels of B12 could potentially lead to a decrease in the production of serotonin ultimately causing or contributing to depression

Chat to your GP

The company manufactures the blockbuster GLP-1 receptor agonist for weight management marketed as Wegovy

Recently we have shown that GLP-1 activates afferent renal nerves to increase efferent renal sympathetic nerve activity that negates the diuresis and natriuresis produced by GLP-1 in normal rats [24]